Sensei Biotherapeutics In... (SNSE)
NASDAQ: SNSE
· Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT
Sensei Biotherapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -547.93 | -7.23 | -7.93 | -10.37 | -10.46 | -16.45 | -11.68 | -14.33 | -18.53 | -22.75 | -18.41 | -18.47 | -33.64 | -28.73 | -94.71 | -166.13 | -152.77 | -172.28 |
PEG Ratio | -0.41 | 0.56 | -1.15 | -2.9 | 0.84 | -2.47 | -1.64 | 1.48 | 3.06 | 1.30 | 3.87 | -0.78 | 2.24 | -0.99 | 30.31 | n/a | 6.42 | -3.1 |
PS Ratio | n/a | n/a | 453.34 | n/a | n/a | n/a | 121.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 396.07 | 6.21 | 6.42 | 6.57 | 5.72 | 9.00 | 5.34 | 5.75 | 8.78 | 9.76 | 8.86 | 8.35 | 11.07 | 10.46 | 24.22 | 41.47 | 36.60 | 32.08 |
P/FCF Ratio | -1.83K | -27.98 | -42.58 | -54.99 | -50.63 | -68.74 | -56.21 | -87.58 | -73.28 | -77.9 | -94.98 | -135.02 | -116.63 | -131.48 | -422.26 | -1.08K | -896.12 | -488.16 |
P/OCF Ratio | -1.83K | -27.98 | -42.58 | -54.99 | -51.58 | -69.07 | -56.21 | -87.58 | -73.5 | -78.9 | -95.69 | -139.99 | -117.14 | -131.71 | -450.97 | -1.15K | -987.41 | -510.24 |
OCF/S Ratio | n/a | n/a | -10.65 | n/a | n/a | n/a | -2.17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.09 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.02 | 0.01 | 0.00 | 0.00 |
Quick Ratio | 7.64 | 6.82 | 7.70 | 8.84 | 10.90 | 12.07 | 11.92 | 11.57 | 15.13 | 13.00 | 11.98 | 13.95 | 23.46 | 18.27 | 30.38 | 30.05 | 42.22 | 69.81 |
Current Ratio | 7.64 | 6.82 | 7.70 | 8.84 | 10.90 | 12.07 | 11.92 | 11.57 | 15.13 | 13.00 | 11.98 | 13.95 | 23.46 | 18.27 | 30.38 | 30.05 | 42.22 | 69.81 |
Asset Turnover | n/a | n/a | 0.01 | n/a | n/a | n/a | 0.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 520.60 | 559.54 | -486.71 | -372.52 | -324.46 | -311.79 | -262.65 | -234.45 | -267.82 | -262.1 | n/a | -1.39K | -62.28 | -51.39 | -30.76 | -48.21 | -66.56 | -2.66K |
Return on Equity | -0.18 | -0.21 | -0.2 | -0.16 | -0.14 | -0.14 | -0.11 | -0.1 | -0.12 | -0.11 | -0.12 | -0.11 | -0.08 | -0.09 | -0.06 | -0.06 | -0.06 | -0.05 |
Return on Assets | -0.16 | -0.18 | -0.17 | -0.14 | -0.12 | -0.12 | -0.1 | -0.09 | -0.1 | -0.09 | -0.11 | -0.1 | -0.08 | -0.08 | -0.06 | -0.06 | -0.06 | -0.05 |
Return on Invested Capital | -0.17 | -0.21 | -0.2 | -0.16 | -0.13 | -0.14 | -0.11 | -0.1 | -0.11 | -0.11 | -0.12 | -0.11 | -0.08 | -0.08 | -0.06 | -0.07 | -0.06 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 0.95 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -14.28 | n/a | n/a | n/a | -2.61 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -14.28 | n/a | n/a | n/a | -2.61 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -15.21 | n/a | n/a | n/a | -2.86 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -14 | n/a | n/a | n/a | -2.55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |